AMINO
AMINO GmbH is a German B2B manufacturer of pharmaceutical-grade amino acids, betaine, and APIs serving global pharmaceutical, biopharmaceutical, and nutritional companies through GMP-compliant multi-purpose facilities in Germany and South Africa.
- Company typePrivate
- Founded1958
- HeadquartersFrellstedt, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What AMINO does
AMINO GmbH is a Frellstedt, Germany-based B2B manufacturer of pharmaceutical-grade amino acids, betaine, and related active pharmaceutical ingredients (APIs) founded in 1958 and operating as a wholly-owned subsidiary of Daesang Corp. since December 2025. The company produces 18+ amino acids (including L-Leucine, L-Valine, L-Isoleucine, L-Methionine, L-Phenylalanine, L-Tryptophan, L-Threonine, L-Serine, L-Histidine, L-Glutamine, L-Glutamic acid, L-Cystine, L-Aspartic acid, L-Asparagine, L-Alanine, Glycine, N-Acetyl-L-Tyrosine, N-Acetyl-L-Methionine), Betain (Trimethylglycin), and L-Malic acid at GMP-compliant, multi-purpose facilities using both traditional plant extraction and modern biotechnological fermentation. AMINO also operates two specialized business units: AMixCo Premix GmbH (founded 2018) for customized amino acid premixes, and AMINOVATION (an R&D platform offering process development and regulatory support). Production sites are located in Frellstedt (Germany, headquarters since 1958) and via Amino Manufacturing South Africa (AmSA, established 2015, FSSC-certified for infant formula amino acid processing).
The company sells to global pharmaceutical manufacturers (for drug formulations, infusions, and parenteral applications), biopharmaceutical firms (cell culture media for biomanufacturing), and nutritional/dietary supplement manufacturers (infant formula and clinical nutrition). Pricing is quote-based and tailored to purity grade (EP infusion, EP oral, USP), volume, and regulatory documentation; contracts are typically multi-year. The go-to-market is sales-led and combines direct regional sales representatives, wholly-owned subsidiaries in India and Korea, and channel/distribution partnerships (Barentz in North/Central America and India, Skypam in Bangladesh, Croda globally for biopharma since November 2025). Quality and regulatory positioning is the central commercial lever: AMINO holds GMP certification, FDA inspection approval, FSSC 22000 (extended to South Africa in 2025), ISO 50001, SMETA, SEDEX membership, SBTi-validated emissions reduction targets (42% Scope 1+2 by 2030, net-zero by 2050), and EcoVadis Silver 2025 (top 15% globally). The company maintains ~129 employees, with country-specific drug registrations secured across Europe, India, Bangladesh, South Africa, North/Central America, and Asia-Pacific.
AMINO firmographics
Firmographics- Name
- AMINO
- Legal name
- AMINO GmbH
- Website
- https://amino.de
- Company type
- Private
- Founded year
- 1958
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- AMINO GmbH is a German B2B manufacturer of pharmaceutical-grade amino acids, betaine, and APIs serving global pharmaceutical, biopharmaceutical, and nutritional companies through GMP-compliant multi-purpose facilities in Germany and South Africa.
- Ownership category
- akta.pro rank
AMINO industry classification
Industry- Product category
- Pharmaceutical Ingredients (Active Pharmaceutical Ingredients)
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG)
- akta.pro secondary industry
- Malic Acid & Malates (AFAJAGAE)
Keywords
Where AMINO is headquartered
LocationHeadquarters
- HQ city
- Frellstedt
- HQ country
- Germany
- HQ region
- Europe
Offices4 records
Markets served
AMINO business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Amino Acids: B2B sales of pharmaceutical-grade amino acids for use in pharmaceutical formulations, infusion products, oral medications, and cell culture media. Products include L-Leucine, L-Valine, L-Isoleucine, L-Methionine, L-Phenylalanine, L-Tryptophan, L-Threonine, L-Serine, L-Histidine, L-Glutamine, L-Glutamic acid, L-Cystine, L-Aspartic acid, L-Asparagine, L-Alanine, Glycine, N-Acetyl-L-Tyrosine, N-Acetyl-L-Methionine, and Betain.
- AMixCo Premixes: Custom-formulated amino acid premixes developed and sold through the AMixCo Premix GmbH business unit for pharmaceutical and dietary products.
- AMINOVATION R&D Services: Research and development services through AMINOVATION business unit for customer-specific product development, process optimization, and documentation support.
- Regulatory Affairs Services: Expert support in regulatory affairs including drug registration, questionnaire preparation, Drug Master Files, and CEP certificates for international markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B pharmaceutical amino acids - quote-based pricing |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels7 records
AMINO product offering
Product offeringCore offering
AMINO GmbH manufactures pharmaceutical-grade amino acids (including L-Leucine, L-Valine, L-Isoleucine, L-Methionine, L-Phenylalanine, L-Tryptophan, L-Threonine, L-Serine, L-Histidine, L-Glutamine, L-Glutamic acid, L-Cystine, L-Aspartic acid, L-Asparagine, L-Alanine, Glycine, N-Acetyl-L-Tyrosine, N-Acetyl-L-Methionine), Betain (Trimethylglycin), and L-Malic acid as active pharmaceutical ingredients at its GMP-compliant facility in Frellstedt, Germany. The company also offers customized amino acid premixes through its AMixCo subsidiary and R&D/process development services through AMINOVATION, serving global pharmaceutical, biopharmaceutical, and nutritional product manufacturers.
Product overview
AMINO GmbH operates as a B2B manufacturer of pharmaceutical-grade amino acids and related active pharmaceutical ingredients (APIs) from its Frellstedt, Germany facility. The core product portfolio centers on high-purity amino acids for pharmaceutical, biopharmaceutical, and nutritional applications, supported by two specialized business units: AMixCo Premix (established 2018) handles customized amino acid premix formulations, while AMINOVATION provides R&D and process development services from laboratory through production scale. The company also produces Betain (Trimethylglycin) and L-Äpfelsäure as additional pharmaceutical APIs. Products serve target markets including pharmaceutical active ingredients, cell culture media, infant nutrition, and dietary supplements.
Differentiator
Problem solved
Functional benefit
Brands
- AMixCo: AMixCo Premix develops individually formulated amino acid premixes for pharmaceutical and dietary products.
- AMINOVATION
Products and services
- AMINO Core Pharmaceutical Amino Acids Pharmaceutical-grade amino acids (L-Isoleucine, L-Valine, L-Tyrosine, L-Tryptophan, L-Threonine, L-Serine, L-Phenylalanine, L-Methionine, L-Leucine, L-Histidine, L-Glutamine, L-Glutamic acid, L-Cystine, L-Aspartic acid, L-Asparagine, L-Alanine, Glycine, DL-Serine, N-Acetyl-L-Tyrosine, N-Acetyl-L-Methionine) produced at the Frellstedt facility in EP infusion, EP oral, and USP purity grades for use in pharmaceutical formulations, infusion products, oral medications, and cell culture media.
- Betain (Trimethylglycin)
Quantifiable outcome
- Successfully registered 16 amino acids with Indian regulatory authority CDSCO
- +3 more outcomes
Companies that use AMINO
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
AMINO technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
AMINO partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Croda InternationalcoreStrategic partnership announced November 2025 to expand AMINO's biopharma presence. The partnership aims to strengthen global availability of high-purity amino acids for pharmaceutical formulations and biomanufacturing. Croda's global market reach combined with AMINO's precision manufacturing capabilities enables delivery of more innovative, high-quality solutions to accelerate customer product development.
- BarentzcoreStrategic distribution partnership appointed May 2024 for North and Central America. Barentz, a globally leading distributor of Life Sciences ingredients, provides AMINO customers access to high-quality amino acid portfolio. Partnership enables geographic expansion to American markets as part of internationalization strategy.
- Skypam Pvt. Ltd.minorAgency agreement signed April 2024 for Bangladesh market. Skypam, based in Dhaka, provides marketing and sales support for AMINO's pharmaceutical amino acids in Bangladesh, supporting internationalization and market growth objectives.
- Barentz India Pvt. Ltd.minorDistribution collaboration in India working alongside Amino India subsidiary. Barentz India supports AMINO's market presence in the Indian subcontinent.
- Amino Korea Co. Ltd.minorRegional subsidiary in Korea coordinating with Amino India for Asian market expansion and regional strategy.
Scale indicators6 records
Recent moves13 records
Expansion highlights6 records
AMINO competitors and assessment
Company assessmentDirect peers
- Evonik Industries AG: Evonik operates a large specialty/feed amino acids business and serves pharmaceutical customers with high-purity amino acids through similar GMP-certified production and global distribution; directly comparable in product portfolio and customer type.
- FUJIFILM Wako Pure Chemical Corporation: FUJIFILM Wako supplies high-purity amino acids, peptides, and pharmaceutical intermediates globally, sharing AMINO's focus on GMP-grade ingredients for pharma and biopharma applications.
- Ajinomoto Co., Inc. Ajinomoto is the world's largest amino acid producer with extensive pharmaceutical-grade amino acid manufacturing for APIs, infusion, and cell culture media—directly overlapping with AMINO's core portfolio across similar customers and applications.
- Kyowa Hakko Bio Co., Ltd. Kyowa Hakko Bio (subsidiary of Kirin Holdings) is a major Japanese manufacturer of pharmaceutical-grade amino acids, nucleotides, and related APIs—directly serving the same pharma and nutrition end-markets as AMINO.
Broad incumbents
- Siegfried Holding AG: Siegfried is a Swiss API manufacturer offering contract development and manufacturing services—overlapping with AMINO's pharmaceutical API production and regulatory documentation services (DMFs, CEPs).
- Thermo Fisher Scientific: Thermo Fisher supplies amino acids, cell culture media, and bioprocessing products globally for pharma and biopharma production—competing with AMINO in the upstream biomanufacturing supply chain.
- Meihua Group: Meihua is one of China's largest amino acid producers with significant glutamate, lysine, and pharmaceutical-grade amino acid capacity—competing on scale and price in both feed and pharma applications.
- Merck KGaA (Sigma-Aldrich): Merck's Life Science division (Sigma-Aldrich) supplies amino acids and buffers for pharma, biopharma, and research applications—serving overlapping customers across pharma APIs and cell culture media.
- CJ CheilJedang: CJ CheilJedang is a Korean food/feed conglomerate with a substantial amino acid business (animal and food nutrition) similar in geography to Daesang—comparable to AMINO's new parent and a regional competitor in amino acid production.
Others
- Daesang Corporation: Daesang is AMINO's parent (December 2025 acquirer) and a Korean food/feed ingredients company—directly relevant as the new owner operating with overlapping amino acid capabilities in feed applications.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks4 records
Key highlights6 records
Customer concentration
AMINO social profiles
Digital presenceAMINO compliance and trust
Trust signalCompliance9 records
AMINO financial estimates
Financial estimateRevenue estimate
Valuation estimate
AMINO leadership team
Management profileNumber of profiles
Profiles9 records
AMINO subsidiaries and ownership
Company hierarchySubsidiaries3 records
AMINO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AMINO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AMINO
What does AMINO do?
AMINO GmbH manufactures pharmaceutical-grade amino acids (including L-Leucine, L-Valine, L-Isoleucine, L-Methionine, L-Phenylalanine, L-Tryptophan, L-Threonine, L-Serine, L-Histidine, L-Glutamine, L-Glutamic acid, L-Cystine, L-Aspartic acid, L-Asparagine, L-Alanine, Glycine, N-Acetyl-L-Tyrosine, N-Acetyl-L-Methionine), Betain (Trimethylglycin), and L-Malic acid as active pharmaceutical ingredients at its GMP-compliant facility in Frellstedt, Germany. The company also offers customized amino acid premixes through its AMixCo subsidiary and R&D/process development services through AMINOVATION, serving global pharmaceutical, biopharmaceutical, and nutritional product manufacturers.
Is AMINO a public or private company?
AMINO is a private company. It is classified as corporate owned and is currently operating.
When was AMINO founded?
AMINO was founded in 1958. It employs 51 to 100 people.
Where is AMINO based?
AMINO is headquartered in Frellstedt, Germany, in the Europe region.
How does AMINO make money?
Four revenue lines are on record. Pharmaceutical Amino Acids are the primary driver. The others are AMixCo Premixes, AMINOVATION R&D Services and regulatory Affairs Services.
Who are AMINO's main competitors?
Direct peers on record are Evonik Industries AG, FUJIFILM Wako Pure Chemical Corporation, Ajinomoto Co., Inc. and Kyowa Hakko Bio Co., Ltd.. Broad incumbents are Siegfried Holding AG, Thermo Fisher Scientific, Meihua Group, Merck KGaA (Sigma-Aldrich) and CJ CheilJedang. Daesang Corporation is listed as an others.
Does AMINO have an API?
No public API is recorded for AMINO.
What industry is AMINO in?
AMINO's product category is Pharmaceutical Ingredients (Active Pharmaceutical Ingredients). Its primary akta.pro industry code is AFAJAKAG, Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine), with a secondary code of AFAJAGAE, Malic Acid & Malates. Its NAICS code is 325411 and its SIC code is 2833.